IMPLANET (ALIMP.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALIMP - FR0013470168 - Common Stock
ALIMP.PA Key Statistics, Chart & Performance
The current stock price of ALIMP.PA is 0.248 EUR. In the past month the price increased by 31.22%. In the past year, price increased by 104.96%.
ALIMP.PA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ALIMP.PA. When comparing the yearly performance of all stocks, ALIMP.PA is one of the better performing stocks in the market, outperforming 94.78% of all stocks.
ALIMP.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALIMP.PA. ALIMP.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
ALIMP.PA Financial Highlights
Over the last trailing twelve months ALIMP.PA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 71.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.08% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALIMP.PA Forecast & Estimates
ALIMP.PA Ownership
About ALIMP.PA
Company Profile
Implanet SA engages in manufacturing implants designed for orthopedic surgery. The company is headquartered in Martillac, Nouvelle-Aquitaine and currently employs 44 full-time employees. The company went IPO on 2013-11-25. The company is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The firm's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors, among others. Its activities, and flagship products, include JAZZ (Spine System) and MADISON (Knee implant). JAZZ implant is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery. MADISON implant is designed for first-line prosthetic knee surgery.
Company Info
IMPLANET
Technopole Bordeaux Montesquieu, Allee Francois Magendie
Martillac NOUVELLE-AQUITAINE FR
Employees: 46
Phone: 33557995555
IMPLANET / ALIMP.PA FAQ
What does IMPLANET do?
Implanet SA engages in manufacturing implants designed for orthopedic surgery. The company is headquartered in Martillac, Nouvelle-Aquitaine and currently employs 44 full-time employees. The company went IPO on 2013-11-25. The company is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The firm's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors, among others. Its activities, and flagship products, include JAZZ (Spine System) and MADISON (Knee implant). JAZZ implant is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery. MADISON implant is designed for first-line prosthetic knee surgery.
What is the current price of ALIMP stock?
The current stock price of ALIMP.PA is 0.248 EUR. The price decreased by -3.13% in the last trading session.
Does ALIMP stock pay dividends?
ALIMP.PA does not pay a dividend.
How is the ChartMill rating for IMPLANET?
ALIMP.PA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How many employees does IMPLANET have?
IMPLANET (ALIMP.PA) currently has 46 employees.
What is IMPLANET worth?
IMPLANET (ALIMP.PA) has a market capitalization of 35.60M EUR. This makes ALIMP.PA a Nano Cap stock.